Regulations.gov document
Letter from U.S. Patent and Trademark Office to Oblon Spivak McClelland Maier and Neustadt…
Other · FDA-2012-E-0196 · posted Feb 24, 2015
Key facts
| Document ID | FDA-2012-E-0196-0021 |
|---|---|
| Title | Letter from U.S. Patent and Trademark Office to Oblon Spivak McClelland Maier and Neustadt LLP |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2012-E-0196 |
| Posted | Feb 24, 2015 |
| Comment period opens | Feb 24, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: